查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595097

整形外科生物材料市场：按材料类型、按应用划分 - 2025-2030 年全球预测

Orthopedic Biomaterials Market by Material Type (Calcium Phosphate Cement, Ceramics & Bioactive Glasses, Composites), Application (Bio-Resorbable Tissue Fixation, Joint Replacement or Reconstruction, Orthobiologics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年整形外科生物材料市场估值为163.2亿美元，预计2024年将达到177.9亿美元，复合年增长率为9.39%，2030年将达到305.9亿美元。

整形外科生物材料包括各种用于支撑、强化或取代受损骨骼和关节的天然和合成材料。这些材料对于推进肌肉骨骼疾病的治疗至关重要，并在外科植入、组织工程和再生医学中发挥重要作用。整形外科生物材料的需求源自于整形外科损伤和关节炎、骨质疏鬆症和创伤等病症发生率的增加。最终用途主要是医院、专科诊所和学术研究机构。关键的成长要素包括全球人口老化、运动相关损伤的增加以及导致生物相容性、强度和与人体组织融合性增强的新型生医材料的技术创新。此外，微创手术的需求正在推动市场扩张，先进陶瓷、聚合物、复合材料和生物可吸收材料正在提供创新机会。为了利用这些机会，公司应该专注于开发模仿自然组织特性的生物材料，促进患者康復并最大限度地降低排斥率。产业公司和研究机构之间的合作可以加速生物列印和个人化医疗应用的进步。然而，市场开拓的挑战包括高昂的开发成本、严格的监管要求以及潜在的生物相容性问题。此外，该产业还面临平衡成本效率和品质的竞争压力，这也是对创新的限制。创新和研究的最佳领域包括用于整形外科植入的生物陶瓷、用于即时生理监测的智慧生物材料以及用于改善材料性能的奈米技术应用。解决这些领域的问题使公司能够提供差异化的产品，以满足患者和医疗保健提供者不断变化的需求。为了在这个动态的格局中定位自己，了解市场的竞争强度至关重要，其特点是大型企业和新兴参与企业寻求技术领先地位。

主要市场统计
基准年[2023] 163.2亿美元
预测年份 [2024] 177.9亿美元
预测年份 [2030] 305.9亿美元
复合年增长率（%） 9.39%

市场动态：快速发展的整形外科生物材料市场的关键市场洞察

供需的动态交互作用正在改变整形外科生物材料市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 整形外科疾病和病症的盛行率增加
    • 整形外科生物材料的最新趋势
    • 运动和事故造成的伤害增加
  • 市场限制因素
    • 对整形外科生物材料可扩展性的担忧
  • 市场机会
    • 对整形外科手术的需求不断增长
    • 扩大医疗基础设施
  • 市场挑战
    • 替代品的可用性

波特五力：驾驭整形外科生物材料市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解整形外科生物材料市场的外部影响

外部宏观环境因素在塑造整形外科生物材料市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解整形外科生物材料市场的竞争格局

对整形外科生物材料市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵整形外科生物材料市场供应商绩效评估

FPNV定位矩阵是评估整形外科生物材料市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划整形外科生物材料市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对整形外科生物材料市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 整形外科疾病和病症的盛行率增加
      • 整形外科生物材料的最新趋势
      • 运动和事故造成的伤害增加
    • 抑制因素
      • 对整形外科生物材料可扩展性的担忧
    • 机会
      • 整形外科手术需求增加
      • 扩大医疗基础设施
    • 任务
      • 替代品的可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章按材料类型分類的整形外科生物材料市场

  • 磷酸钙骨水泥
  • 陶瓷和生物活性玻璃
  • 复合材料
  • 金属
  • 聚合物

第七章整形外科生物材料市场：依应用分类

  • 生物可吸收组织固定
  • 关节重建或重组
  • 生物性骨材
  • 整形外科植入
  • 关节内粘稠补充疗法

第八章美洲整形外科生物材料市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太整形外科生物材料市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲整形外科生物材料市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Arthrex, Inc.
  • Biomatcan Ltd.
  • CAM Bioceramics BV
  • Collagen Matrix
  • Evonik Industries AG
  • Globus Medical Inc.
  • Heraeus Holding
  • Invibio Ltd. by Victrex PLC
  • Koninklijke DSM NV
  • Matexcel
  • Medtronic PLC
  • NuVasive, Inc.
  • Stryker Corporation
  • Victrex PLC
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-742BD5182EB5

The Orthopedic Biomaterials Market was valued at USD 16.32 billion in 2023, expected to reach USD 17.79 billion in 2024, and is projected to grow at a CAGR of 9.39%, to USD 30.59 billion by 2030.

Orthopedic biomaterials encompass a range of natural and synthetic substances used to support, enhance, or replace damaged bones and joints. These materials are vital in advancing treatments for musculoskeletal disorders, playing a crucial role in surgical implants, tissue engineering, and regenerative medicine. The necessity for orthopedic biomaterials arises from the increasing incidence of orthopedic injuries and conditions such as arthritis, osteoporosis, and trauma. Their application spans across joint replacements, fracture fixation, and spinal augmentation, with end-use sectors primarily comprising hospitals, specialized clinics, and academic research institutes. Key growth factors include the aging global population, rising sports-related injuries, and technological innovations leading to new biomaterials that offer enhanced biocompatibility, strength, and integration with human tissue. Furthermore, the demand for minimally invasive procedures fuels market expansion, with advanced ceramics, polymers, composites, and bio-resorbable materials presenting opportunities for innovation. To capitalize on these opportunities, companies should focus on developing biomaterials that mimic natural tissue properties, enhance patient recovery, and minimize rejection rates. Collaborations between industry players and research institutions can drive advancements in bioprinting and personalized medicine applications. However, market growth is challenged by high development costs, stringent regulatory requirements, and potential biocompatibility issues. Additionally, the sector faces competitive pressure to balance cost-efficiency with quality, which can restrain innovation. The best areas for innovation and research include bioceramics for orthopedic implants, smart biomaterials capable of real-time physiological monitoring, and nanotechnology applications enhancing material properties. By addressing these areas, companies can deliver differentiated products that align with evolving patient and healthcare provider needs. Understanding the market's highly competitive nature, characterized by major players and emerging entrants striving for technological leadership, is crucial for positioning in this dynamic landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 16.32 billion
Estimated Year [2024] USD 17.79 billion
Forecast Year [2030] USD 30.59 billion
CAGR (%) 9.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Orthopedic Biomaterials Market

The Orthopedic Biomaterials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of orthopedic diseases and disorders
    • Recent development in orthopedic biomaterials
    • Rising number of sports and accident-related injuries
  • Market Restraints
    • Scalability concerns of orthopedic biomaterials
  • Market Opportunities
    • Rising need for orthopedic surgeries
    • Expanding healthcare infrastructure
  • Market Challenges
    • Availability of alternative

Porter's Five Forces: A Strategic Tool for Navigating the Orthopedic Biomaterials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Orthopedic Biomaterials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Orthopedic Biomaterials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Orthopedic Biomaterials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Orthopedic Biomaterials Market

A detailed market share analysis in the Orthopedic Biomaterials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Orthopedic Biomaterials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Orthopedic Biomaterials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Orthopedic Biomaterials Market

A strategic analysis of the Orthopedic Biomaterials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Orthopedic Biomaterials Market, highlighting leading vendors and their innovative profiles. These include Arthrex, Inc., Biomatcan Ltd., CAM Bioceramics B.V., Collagen Matrix, Evonik Industries AG, Globus Medical Inc., Heraeus Holding, Invibio Ltd. by Victrex PLC, Koninklijke DSM N.V., Matexcel, Medtronic PLC, NuVasive, Inc., Stryker Corporation, Victrex PLC, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Orthopedic Biomaterials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material Type, market is studied across Calcium Phosphate Cement, Ceramics & Bioactive Glasses, Composites, Metal, and Polymers.
  • Based on Application, market is studied across Bio-Resorbable Tissue Fixation, Joint Replacement or Reconstruction, Orthobiologics, Orthopedic Implants, and Viscosupplementation.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of orthopedic diseases and disorders
      • 5.1.1.2. Recent development in orthopedic biomaterials
      • 5.1.1.3. Rising number of sports and accident-related injuries
    • 5.1.2. Restraints
      • 5.1.2.1. Scalability concerns of orthopedic biomaterials
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising need for orthopedic surgeries
      • 5.1.3.2. Expanding healthcare infrastructure
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Orthopedic Biomaterials Market, by Material Type

  • 6.1. Introduction
  • 6.2. Calcium Phosphate Cement
  • 6.3. Ceramics & Bioactive Glasses
  • 6.4. Composites
  • 6.5. Metal
  • 6.6. Polymers

7. Orthopedic Biomaterials Market, by Application

  • 7.1. Introduction
  • 7.2. Bio-Resorbable Tissue Fixation
  • 7.3. Joint Replacement or Reconstruction
  • 7.4. Orthobiologics
  • 7.5. Orthopedic Implants
  • 7.6. Viscosupplementation

8. Americas Orthopedic Biomaterials Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Orthopedic Biomaterials Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Orthopedic Biomaterials Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Arthrex, Inc.
  • 2. Biomatcan Ltd.
  • 3. CAM Bioceramics B.V.
  • 4. Collagen Matrix
  • 5. Evonik Industries AG
  • 6. Globus Medical Inc.
  • 7. Heraeus Holding
  • 8. Invibio Ltd. by Victrex PLC
  • 9. Koninklijke DSM N.V.
  • 10. Matexcel
  • 11. Medtronic PLC
  • 12. NuVasive, Inc.
  • 13. Stryker Corporation
  • 14. Victrex PLC
  • 15. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. ORTHOPEDIC BIOMATERIALS MARKET RESEARCH PROCESS
  • FIGURE 2. ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ORTHOPEDIC BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ORTHOPEDIC BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ORTHOPEDIC BIOMATERIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ORTHOPEDIC BIOMATERIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY CERAMICS & BIOACTIVE GLASSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY METAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY BIO-RESORBABLE TISSUE FIXATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY JOINT REPLACEMENT OR RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY ORTHOBIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY VISCOSUPPLEMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM ORTHOPEDIC BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ORTHOPEDIC BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. ORTHOPEDIC BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2023